Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 11, 2003 3:40:24 PM
"Tony inedicated it took one year just to come to a working agreement,that puts us at Nov,2002. A 1 year term puts it at Nov.,2003 completed".
In November 2001, NYU's Mary Lea Johnson Richards Organ Transplantation Center agreed to provide us with informed consent qualified patient specimens and matching clinical data. We will genetically screen the specimens for markers
and/or marker sets that can be used to distinguish between drug responders and non-responders. To do this, we will employ proprietary genotyping protocols, data resources (the PHENOME SNP database) and our informatics platform. The goal of the project is to identify pharmacogenomic classifiers that could be used to match renal transplantation patients with the optimal immunosuppressant for their genetic architecture. We expect the project to take about one year to complete, and we expect the results to extend to patients for a wide range of transplantation procedures. The Mary Lea Johnson Richards Organ Transplantation Center is one of the busiest and most successful transplant programs in the United States
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM